Aspirin fights cancer. This 4,000-year-old painkiller stops certain tumors from forming and spreading. New findings already reshape health policies worldwide.
Nick James worried about cancer after family tragedies. His mum died from it. His brother and others developed bowel cancer. Genetic tests confirmed his Lynch Syndrome diagnosis.
James joined the first aspirin trial for cancer prevention. He takes a daily dose. Professor John Burn leads the study at Newcastle University. James stays cancer-free after 10 years.
Lynch Syndrome patients face 80% bowel cancer risk. Aspirin drops those odds dramatically.
Recent trials confirm aspirin’s power. Countries update guidelines now. High-risk patients start aspirin under doctor supervision. Scientists finally explain why it works so well.
Ancient Origins
Archaeologists found 4,400-year-old clay tablets in ancient Mesopotamia. They listed willow tree remedies. The body converts willow’s salicin into salicylic acid.
This chemical closely matches modern aspirin. Ancient Egyptians, Greeks, and Romans used similar treatments. Aspirin evolved into today’s gentler stomach formula.
Modern Cancer Shield
Aspirin blocks cancer pathways. It stops tumors from growing blood vessels. It triggers cancer cell death. It curbs inflammation that fuels tumor spread.
These discoveries transform prevention. High-risk families gain a simple weapon. Doctors prescribe aspirin strategically now.
